WT1 RNA as a Marker of Minimal Residual Disease in Acute Myeloid Leukemia

被引：0
|
作者：
Moore, F. R. [1 ]
Yang, F. [1 ]
Press, R. D. [1 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2010年 / 12卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：872 / 872
页数：1
相关论文
共 50 条
  • [1] The Role of Wilms' Tumor Gene (WT1) Expression as a Marker of Minimal Residual Disease in Acute Myeloid Leukemia
    Lazzarotto, Davide
    Candoni, Anna
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (12)
  • [2] WT1 Monitoring of Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukemia
    Malagola, Michele
    Skert, Crisitina
    Morello, Enrico
    Antoniazzi, Francesca
    Borlenghi, Erika
    Turra, Alessandro
    Pagani, Chiara
    Ribolla, Rossella
    Cancelli, Valeria
    Cattina, Federica
    Alghisi, Elisa
    Bernardi, Simona
    Perucca, Simone
    Di Palma, Andrea
    Ruggeri, Giuseppina
    Rossi, Giuseppe
    Caimi, Luigi
    Russo, Domenico
    BLOOD, 2014, 124 (21)
  • [3] COULD WT1 GENE EXPRESSION BE USEFUL MARKER FOR MONITORING OF MINIMAL RESIDUAL DISEASE IN PEDIATRIC ACUTE MYELOID LEUKEMIA?
    Ksiazek, Teofila
    Balwierz, Walentyna
    Wator, Gracjan
    Szewczyk, Katarzyna
    Klekawka, Tomasz
    Matysiak, Michal
    Sikorska-Fic, Barbara
    Adamkiewicz-Drozynska, Elzbieta
    Maciejka-Kapuscinska, Lucyna
    Kowalczyk, Jerzy
    Wojcik, Beata
    Mlynarski, Wojciech
    Jasinska, Aleksandra
    Szczepanski, Tomasz
    Tomaszewska, Renata
    Wysocki, Mariusz
    Koltan, Sylwia
    Sobol, Grazyna
    Mizia-Malarz, Agnieszka
    Urasinski, Tomasz
    Kamienska, Elzbieta
    Krawczuk-Rybak, Maryna
    Muszynska-Roslan, Katarzyna
    Wieczorek, Maria
    Karpinska-Derda, Irena
    Karolczuk, Grazyna
    Pohorecka, Joanna
    Chybicka, Alicja
    Potocka, Kinga
    Badowska, Wanda
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1038 - 1039
  • [4] WT1 expression as a marker of minimal residual disease predicts outcome in acute myeloid leukemia when measured post-consolidation
    Gray, James X.
    McMillen, Lyle
    Mollee, Peter
    Paul, Sanjoy
    Lane, Steven
    Bird, Robert
    Gill, Devinder
    Saal, Russell
    Marlton, Paula
    LEUKEMIA RESEARCH, 2012, 36 (04) : 453 - 458
  • [5] Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease
    Tsuboi, A.
    Oka, Y.
    Kyo, T.
    Katayama, Y.
    Elisseeva, O. A.
    Kawakami, M.
    Nishida, S.
    Morimoto, S.
    Murao, A.
    Nakajima, H.
    Hosen, N.
    Oji, Y.
    Sugiyama, H.
    LEUKEMIA, 2012, 26 (06) : 1410 - 1413
  • [6] Expression patterns of WT1 and PRAME in acute myeloid leukemia patients and their usefulness for monitoring minimal residual disease
    Qin, YaZhen
    Zhu, HongHu
    Jiang, Bin
    Li, JinLan
    Lu, XiJing
    Li, LingDi
    Ruan, GuoRui
    Liu, YanRong
    Chen, ShanShan
    Huang, XiaoJun
    LEUKEMIA RESEARCH, 2009, 33 (03) : 384 - 390
  • [7] Long-term WT1 peptide vaccination for patients with acute myeloid leukemia with minimal residual disease
    A Tsuboi
    Y Oka
    T Kyo
    Y Katayama
    O A Elisseeva
    M Kawakami
    S Nishida
    S Morimoto
    A Murao
    H Nakajima
    N Hosen
    Y Oji
    H Sugiyama
    Leukemia, 2012, 26 : 1410 - 1413
  • [8] WT1 AS A NEW PROGNOSTIC FACTOR AND A NEW MARKER FOR THE DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE-LEUKEMIA
    INOUE, K
    SUGIYAMA, H
    OGAWA, H
    NAKAGAWA, M
    YAMAGAMI, T
    MIWA, H
    KITA, K
    HIRAOKA, A
    MASAOKA, T
    NASU, K
    KYO, T
    DOHY, H
    NAKAUCHI, H
    ISHIDATE, T
    AKIYAMA, T
    KISHIMOTO, T
    BLOOD, 1994, 84 (09) : 3071 - 3079
  • [9] Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia
    Zhang, R.
    Yang, J. Y.
    Sun, H. Q.
    Jia, H.
    Liao, J.
    Shi, Y. J.
    Li, G.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (14) : 2679 - 2688
  • [10] WT1 Expression Levels at Diagnosis and as a Marker of Minimal Residual Disease (MRD) in Patients with Acute Myeloid Leukaernia (AML).
    Gray, James X.
    McMillen, Lyle
    Saal, Russell
    Lane, Steven
    Mollee, Peter
    Bird, Robert
    Gill, Devinder
    Marlton, Paula
    BLOOD, 2009, 114 (22) : 1035 - 1035
12345